This Article Full Text Full Text (PDF) All Versions of this Article: 35/3/742    most recent 01.STR.0000117572.56058.2Av1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giele, J. L.P. Search for Related Content PubMed PubMed Citation Articles by Giele, J. L.P. Related Collections Epidemiology CT and MRI Risk Factors Computerized tomography and Magnetic Resonance Imaging Risk Factors for Stroke

(Stroke. 2004;35:742.)
© 2004 American Heart Association, Inc.

Original Contributions

Silent Brain Infarcts in Patients With Manifest Vascular Disease

Janneke L.P. Giele, MsC; Theo D. Witkamp, MD; Willem P.T.M. Mali, MD, PhD Yolanda van der Graaf, MD, PhD for the SMART Study Group

From the Julius Center for Health Sciences and Primary Care (J.L.P.G., Y.v.d.G.) and Department of Radiology (T.D.W., W.P.T.M.M.), University Medical Center Utrecht, Utrecht, Netherlands.

Correspondence to Dr Y. van der Graaf, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, HP D 01 335, PO BOX 85500, 3508 GA Utrecht, Netherlands. E-mail y.vandergraaf{at}jc.azu.nl

Background and Purpose— Silent infarcts are frequently found on MRIs of brains of healthy elderly persons (aged >60 years). The purpose of this study was to investigate the prevalence and determinants of silent infarcts in a population of patients with clinically manifest vascular disease.

Methods— To detect silent infarcts, MR images were made in 308 participants of the Second Manifestations of ARTerial disease (SMART) study (mean age, 58 years) without prior stroke or transient ischemic attack. These are patients referred to the University Medical Center Utrecht because of atherosclerotic vascular disease. Risk factors were assessed by questionnaire and by physical, ultrasonographic, and laboratory examinations.

Results— Silent infarcts were found in 51 patients (17%). Most infarcts (62%) were located in white matter, 20% in basal ganglia, 14% in brain stem and cerebellum, and 4% in cortical area. Categorical determinants for presence of silent infarct(s) that remained (borderline) significant after adjustment for age were hypertension (odds ratio [OR]=2.2; 95% CI, 1.2 to 4.2), abdominal aortic aneurysm (OR=2.4; 95% CI, 0.9 to 6.4), severe renal failure (OR=7.3; 95% CI, 2.1 to 25.2), and hyperhomocysteinemia (OR=2.6; 95% CI, 1.1 to 5.9).

Conclusions— Patients with manifest vascular disease are at risk for silent infarcts at a younger age. In particular, patients with the aforementioned risk factors should be considered for treatment or (secondary) prevention.

Key Words: cerebral infarction • epidemiology • magnetic resonance imaging

This article has been cited by other articles:

				B. van Harten, J. Oosterman, D. Muslimovic, B.-J. P. van Loon, P. Scheltens, and H. C. Weinstein Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus Age Ageing, March 1, 2007; 36(2): 164 - 170. [Abstract] [Full Text] [PDF]

				B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels Brain Imaging in Patients With Diabetes: A systematic review. Diabetes Care, November 1, 2006; 29(11): 2539 - 2548. [Full Text] [PDF]

				T. Hoshi, K. Kitagawa, H. Yamagami, S. Furukado, H. Hougaku, and M. Hori Relations of Serum High-Sensitivity C-Reactive Protein and Interleukin-6 Levels With Silent Brain Infarction Stroke, April 1, 2005; 36(4): 768 - 772. [Abstract] [Full Text] [PDF]